Despite initially underperforming in the United States, Danny Boyle’s sequel 28 Years Later has proved to have a tremendous set of legs.
Although the US gross is still under initial projections, the film has continued to hold strong in the weeks since its release. In its third week on the US box-office charts, 28 Years Later bested horror newcomer M3GAN 2.0, which is no small feat.
Now, with steady US profits continuing to mount, and an incredibly strong European showing these past few weeks, 28 Years Later has crossed the coveted $100 million mark at the global box-office.
Currently sitting pretty at $106 million, the sequel has reached a height not often seen in the zombie sub-genre.
In comparison, 2002’s 28 Days Later had a total gross of $82 million, whereas 2007’s 28 Weeks Later managed only $71 million worldwide. This makes the newest entry the highest grossing film in the series so far, in addition to being the only one to pass $100 million.
With profits expected to continue growing slowly in the coming weeks, 28 Years Later looks like it will top out at $120 million worldwide, doubling its $60 million production budget.
Factoring in marketing and prints, this will see the film turn a profit for Sony, something that wasn’t initially expected after its below-par opening weekend.
It’s safe to assume that worries about the fate of sequel 28 Years Later: The Bone Temple have been soothed, as the film is still on the release schedule for January 16th 2026.
However, Boyle’s hoped-for third entry in his proposed trilogy remains a question mark. Will The Bone Temple have as much staying power at the box-office? We’re intrigued to find out.
